The three most significantly increased markers in the plasma of MASH subjects from the inflammatory panel were FGF-21 (Fibroblast Growth Factor 21), HGF, and ADA (see scatter plots Figure 2a–c). This evidence concerns the gene FGF21 and metabolic dysfunction-associated steatohepatitis.